ABC00838CI

Levothyroxine EP Impurity H

Levothyroxine EP Impurity H is a diiodinated tyrosine derivative featuring a fully iodinated benzene ring (four iodine atoms) and a 3,5-dihydroxybenzoic acid moiety. It lacks the 3'-iodo substitution present in the parent levothyroxine structure, resulting in a truncated side chain. This impurity arises via oxidative degradation pathways during API synthesis, retaining the core aromatic framework but with altered iodination patterns. The compound exhibits strong UV absorbance due to conjugated aromatic systems and hydroxyl groups, enabling detection in chromatographic profiles. It serves as a critical HPLC reference standard for quantifying process-related impurities in levothyroxine formulations.

On Request
Molecular Formula C13H6I4O4
Molecular Weight 733.8000
CAS Number 2055-97-2 โœ“ Verified
PubChem CID 6451352 โ†—
Purity N/A
Product Type API Impurity
Parent Drug Levothyroxine
Lead Time On Request
IUPAC Name 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzoic acid
Official Reference Standards
Std Catalog # Quantity Price
USP 1A10830 โ†— 10 mg USD 775.00

๐Ÿ“ Synonyms

2055-97-2 3,3',5,5'-Tetraiodothyroformic acid Benzoic acid, 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo- 069P3V0KG2 TFA-4 DTXSID00174553 RefChem:910528 DTXCID9097044 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzoic acid Tetraiodothyroformic Acid

๐Ÿ”ฌ Chemical Identifiers

C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C(=O)O
InChI=1S/C13H6I4O4/c14-7-3-6(4-8(15)11(7)18)21-12-9(16)1-5(13(19)20)2-10(12)17/h1-4,18H,(H,19,20)
HKJUOMPYMPXLFS-UHFFFAOYSA-N

Related Products